These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8371354)

  • 1. Rabies virus antinucleoprotein antibody protects against rabies virus challenge in vivo and inhibits rabies virus replication in vitro.
    Lodmell DL; Esposito JJ; Ewalt LC
    J Virol; 1993 Oct; 67(10):6080-6. PubMed ID: 8371354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection.
    Lodmell DL; Sumner JW; Esposito JJ; Bellini WJ; Ewalt LC
    J Virol; 1991 Jun; 65(6):3400-5. PubMed ID: 2033678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
    Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
    Turki I; Hammami A; Kharmachi H; Mousli M
    Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein.
    Fekadu M; Shaddock JH; Sumner JW; Sanderlin DW; Knight JC; Esposito JJ; Baer GM
    J Wildl Dis; 1991 Oct; 27(4):681-4. PubMed ID: 1758034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of mice vaccinated with rabies virus internal structural proteins to lethal infection.
    Takita-Sonoda Y; Fujii H; Mifune K; Ito Y; Hiraga M; Nishizono A; Mannen K; Minamoto N
    Arch Virol; 1993; 132(1-2):51-65. PubMed ID: 8352659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice.
    Lafon M; Bourhy H; Sureau P
    Vaccine; 1988 Aug; 6(4):362-8. PubMed ID: 2461007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
    Seroka D
    Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody production in milk serum after virus instillation of goat mammary gland VI. "Sham infection" with special reference to rabies.
    Mitchell CA; Guerin LF; Pasieka AE
    Can J Comp Med; 1974 Jan; 38(1):14-7. PubMed ID: 4272951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine.
    Yusibov V; Hooper DC; Spitsin SV; Fleysh N; Kean RB; Mikheeva T; Deka D; Karasev A; Cox S; Randall J; Koprowski H
    Vaccine; 2002 Aug; 20(25-26):3155-64. PubMed ID: 12163267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
    Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
    Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals.
    Niederhäuser S; Bruegger D; Zahno ML; Vogt HR; Peterhans E; Zanoni R; Bertoni G
    Vaccine; 2008 Dec; 26(52):6749-53. PubMed ID: 18955098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of brain-associated rabies neutralizing substance.
    Gough PM; Dierks RE; Russell RM; Archer BG
    J Infect Dis; 1974 Apr; 129(4):456-60. PubMed ID: 4206247
    [No Abstract]   [Full Text] [Related]  

  • 15. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
    Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
    Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus].
    Shmarov MM; Tutykhina IL; Logunov DIu; Verkhovskai LV; Nedosekov VV; Tsybanov SZh; Novikov BV; Narodnitskiĭ BS; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):69-71. PubMed ID: 16941876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein.
    Esposito JJ; Knight JC; Shaddock JH; Novembre FJ; Baer GM
    Virology; 1988 Jul; 165(1):313-6. PubMed ID: 3291388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus.
    Wang Y; Xiang Z; Pasquini S; Ertl HC
    J Virol; 1998 Mar; 72(3):1790-6. PubMed ID: 9499029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of a novel zipFv using leucine zipper motif against rabies virus glycoprotein G with improved protection potency in vivo.
    Xi H; Zhang K; Yin Y; Gu T; Sun Q; Li Z; Cheng Y; Jiang C; Kong W; Wu Y
    Immunol Lett; 2017 Jun; 186():9-14. PubMed ID: 28389318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.